about
A novel ER alpha-mannosidase-like protein accelerates ER-associated degradationMolecular basis of galactosemia: mutations and polymorphisms in the gene encoding human galactose-1-phosphate uridylyltransferaseThree human elastase-like genes coordinately expressed in the myelomonocyte lineage are organized as a single genetic locus on 19pterAlleles at the PRB3 locus coding for a disulfide-bonded human salivary proline-rich glycoprotein (Gl 8) and a null in an Ashkenazi JewAlpha1-antitrypsin deficiency. 2: genetic aspects of alpha(1)-antitrypsin deficiency: phenotypes and genetic modifiers of emphysema riskProlastin, a pharmaceutical preparation of purified human alpha1-antitrypsin, blocks endotoxin-mediated cytokine releaseDistinctive serum protein profiles involving abundant proteins in lung cancer patients based upon antibody microarray analysis.Crystal structure of an uncleaved alpha 1-antitrypsin reveals the conformation of its inhibitory reactive loopChallenges and Prospects for Alpha-1 Antitrypsin Deficiency Gene TherapyPlasma levels of alpha1-antichymotrypsin and secretory leukocyte proteinase inhibitor in healthy and chronic obstructive pulmonary disease (COPD) subjects with and without severe alpha1-antitrypsin deficiency.Expression of human alpha1-proteinase inhibitor in Aspergillus niger.Differential regulation of gene activity and chromatin structure within the human serpin gene cluster at 14q32.1 in macrophage microcell hybrids.High-level expression of biologically active human alpha 1-antitrypsin in the milk of transgenic miceAutomated DNA diagnostics using an ELISA-based oligonucleotide ligation assay.Modulation of secretory leukoprotease inhibitor gene expression in human bronchial epithelial cells by phorbol ester.Alpha 1-antitrypsin deficiency, emphysema, and liver disease. Genetic basis and strategies for therapy.The Z type variation of human alpha 1-antitrypsin causes a protein folding defect.Adipose tissue-derived mesenchymal stem cell-based liver gene deliveryRole of elastases in the pathogenesis of chronic obstructive pulmonary disease: implications for treatmentCharacterization of the molecular basis of the alpha 1-antitrypsin F allele.Alpha 1-antitrypsin Null(isola di procida): an alpha 1-antitrypsin deficiency allele caused by deletion of all alpha 1-antitrypsin coding exonsAlternative transcripts of the SERPINA1 gene in alpha-1 antitrypsin deficiencyConformational properties of the disease-causing Z variant of α1-antitrypsin revealed by theory and experiment.Coordinated DNA methylation and gene expression changes in smoker alveolar macrophages: specific effects on VEGF receptor 1 expressionAdeno-associated virus-based gene therapy for inherited disorders.Expression and Purification of Functionally Active Recombinant Human Alpha 1-Antitrypsin in Methylotrophic Yeast Pichia pastoris.Polymorphisms in the promoter region of neutrophil elastase gene and lung cancer riskAlpha 1-antitrypsin deficiency: pathogenesis and treatment.Sustained transgene expression despite T lymphocyte responses in a clinical trial of rAAV1-AAT gene therapy.Pilot study using proteomics to identify predictive biomarkers of necrotizing enterocolitis from buccal swabs in very low birth weight infants.Current status of gene therapy for α-1 antitrypsin deficiency.Alpha-1-Antitrypsin Antagonizes Cisplatin-Induced Cytotoxicity in Prostate Cancer (PC3) and Melanoma Cancer (A375) Cell Lines.Conserved amino acid residues in the COOH-terminal tail are indispensable for the correct folding and localization and enzyme activity of neutral ceramidase.Alpha-1-antitrypsin stimulates fibroblast proliferation and procollagen production and activates classical MAP kinase signalling pathways.A novel SV40-based vector successfully transduces and expresses an alpha 1-antitrypsin ribozyme in a human hepatoma-derived cell line.A novel transcription factor regulates expression of the vacuolar H+-ATPase B2 subunit through AP-2 sites during monocytic differentiation.Genotypes and serum concentrations of human alpha-1-antitrypsin "P" protein variants in a clinical population.Current issues in the management of chronic obstructive pulmonary diseases.Pulmonary cell biology.A highly conserved motif at the COOH terminus dictates endoplasmic reticulum exit and cell surface expression of NKCC2.
P2860
Q24522524-E97E5835-E16A-4543-9BCA-7D3684BDFAF2Q24563815-A6AF9C26-CC82-4654-B659-AA9BF3A4B7ABQ24564102-F6094E95-62FC-4435-9781-7E791C8F8440Q24676635-71F22324-BF84-4CE0-BA83-EEDBFB9FF066Q24678705-B6E93046-178F-41C0-B96B-4111BE9D9E78Q24804783-E9BE4277-5E7B-4717-B622-2547EF959DB3Q24810591-EDFF1D28-EF2C-4471-9B9E-C7F78D68E810Q27732225-E60EE41B-C87E-47A4-9043-2EAB3D726D0AQ28080450-086C9A9A-183D-4BBA-8C92-D5155E790D22Q33270742-664971ED-C37C-48B4-8086-BB3225BF13C9Q33304242-97B73200-AC27-44CE-8677-5949732787E5Q33620545-D028B5DE-249D-449D-87FB-136A1E5D59E1Q33672151-933366F9-49C8-4FB5-A548-53302023B8A1Q33897559-8707B3FE-06F9-4F56-A988-002879153D7CQ34236026-ABED9AEC-765D-438C-BD92-48F550D9E636Q34249676-362197A7-FC85-4ABA-A176-91285FF45568Q34304294-71ED0CFC-3B8E-4DBD-9DFF-B116E64343BDQ34810340-2F9475F6-6308-492F-80AE-5BBE52B79991Q35179153-AA615211-A66B-4EEB-87B0-790DD6FA2BBAQ35196673-69974D08-C94F-4476-AA36-ABDA93EA72E8Q35198446-0EDC5A95-595A-4323-B0D2-15EF032E51ACQ35814577-EDA65206-31C2-4D87-AD98-AB64D606568FQ36045474-2FEE811B-2201-4C34-ABBC-EF5857A0AA7DQ36188916-47C5F196-4229-45CE-B523-A2922DCA4CE3Q36321469-239C6151-666C-4C7C-95B6-A8755F8B1F93Q36571385-663609D6-796C-48FD-86CB-1527A90B9B0CQ36973877-E49D5BD9-1985-4438-A60C-0F19992EB4BEQ37320922-F3F3AE5C-9523-4D1F-9328-4C12F0463550Q37364038-BCFE5C6A-1FC3-4C28-A8C9-AAD0E9F689C3Q37436549-880A24F1-53BC-4786-9AD6-C4B5887D8E96Q38264336-0EE04C52-59DC-48ED-B95B-3607DF50FFBEQ38746895-400F4C23-0B4F-430A-B1D5-938BB4D74DD6Q40559888-D3EACAAE-E7C6-4DB2-AAAA-455D26E77306Q40833512-131C6A91-7470-4AB3-9226-C424FCF575BFQ40952202-FDBDA06A-8675-4FE0-9729-BFC41B5A9406Q41135275-5FA890AB-9F66-4B3C-8F06-86AF830B8BC7Q41608096-210FAC5E-66F8-44B2-8348-8247A6879BA9Q41662462-FFC2B892-FB28-4E5B-BEC3-E5F9BD4F5DAEQ41752319-94BC7EFE-7251-4EC1-A007-67766B4B2000Q41828955-D099B4C9-EDD4-453F-A517-D438018D1A98
P2860
description
1989 nî lūn-bûn
@nan
1989 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1989 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
1989年の論文
@ja
1989年論文
@yue
1989年論文
@zh-hant
1989年論文
@zh-hk
1989年論文
@zh-mo
1989年論文
@zh-tw
1989年论文
@wuu
name
The alpha 1-antitrypsin gene and its deficiency states.
@ast
The alpha 1-antitrypsin gene and its deficiency states.
@en
The alpha 1-antitrypsin gene and its deficiency states.
@nl
type
label
The alpha 1-antitrypsin gene and its deficiency states.
@ast
The alpha 1-antitrypsin gene and its deficiency states.
@en
The alpha 1-antitrypsin gene and its deficiency states.
@nl
prefLabel
The alpha 1-antitrypsin gene and its deficiency states.
@ast
The alpha 1-antitrypsin gene and its deficiency states.
@en
The alpha 1-antitrypsin gene and its deficiency states.
@nl
P1433
P1476
The alpha 1-antitrypsin gene and its deficiency states.
@en
P2093
Crystal RG
P304
P356
10.1016/0168-9525(89)90200-X
P577
1989-12-01T00:00:00Z